Pratama, Rangga Satria Negara Yudi and , Prof. Dr. Muhammad Da'i, M.Si., Apt (2024) Studi Penambatan Molekuler Senyawa [2-metoksi-5-prop-2-enilpirimidin] dan [2-etoksi-5-prop-2-enilpirimidin] Terhadap Protein ERα, ERβ dan HER-2 Sebagai Agen Sitotoksik. Skripsi thesis, Universitas Muhammadiyah Surakarta.
![[img]](https://eprints.ums.ac.id/style/images/fileicons/application_pdf.png) |
PDF (Naskah Publikasi)
Naskah Publikasi [REVISI1]_Rangga Satria Negara_K100200073.pdf Download (849kB) |
|
PDF (Surat Pernyataan Publikasi)
UNGGAH rangga.pdf Restricted to Repository staff only Download (311kB) | Request a copy |
Abstract
In the firstline of breast cancer, anti-estrogen drugs such as tamoxifen and raloxifen are still the main therapy in the treatment of breast cancer patients. However, the use of these drugs still causes several side effects, most of which can be detrimental to patients. This encourages the development of therapies for breast cancer that aim to find therapies that have effective and efficient therapeutic targets. This study uses Acetoxycavicol acetate compound derivatives with ERα, ERβ, and HER-2 proteins. The compounds and proteins were processed using Silico's Molecular Docking method. ACA-derived compounds used in this study are MPE [2-methoxy-5-prop-2-enylpyrimidine] and EPE [2-ethoxy-5-prop-2-enylpyrimidine] compounds, then additional original ACA compounds and also erlotinib compounds as comparison compounds. The docking results in affinity values of MPE compounds against ERα, ER-β, and HER-2 receptors are -9.8; -8.5, and -7.5, respectively. The EPE compound produced affinity values of -9.8; -8.7 and -7.1, respectively. The results of RMSD on MPE compounds in order are 1.102; 1.037 and 1.515. In the EPE compound, the resulting RMSD is 1.059; 1.326, and 1.360, respectively. The results of small affinity values in the docking process show that these two compounds qualify as substances that have the potential to become breast cancer therapeutic agents.
| Item Type: | Thesis (Skripsi) |
|---|---|
| Uncontrolled Keywords: | breast cancer, molecular docking, Acetoxycavicol acetate. |
| Subjects: | R Medicine > RM Therapeutics. Pharmacology |
| Divisions: | Fakultas Farmasi > Farmasi |
| Depositing User: | RANGGA SATRIA NEGARA YUDI PRATAMA |
| Date Deposited: | 15 Aug 2024 06:14 |
| Last Modified: | 15 Aug 2024 06:14 |
| URI: | http://eprints.ums.ac.id/id/eprint/127068 |
Actions (login required)
 |
View Item |
